The cost-effectiveness of returning incidental findings from next-generation genomic sequencing
出版年份 2014 全文链接
标题
The cost-effectiveness of returning incidental findings from next-generation genomic sequencing
作者
关键词
-
出版物
GENETICS IN MEDICINE
Volume 17, Issue 7, Pages 587-595
出版商
Springer Nature
发表日期
2014-11-14
DOI
10.1038/gim.2014.156
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia
- (2014) Zanfina Ademi et al. Journal of Clinical Lipidology
- Actionable, Pathogenic Incidental Findings in 1,000 Participants’ Exomes
- (2013) Michael O. Dorschner et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer
- (2013) Uri Ladabaum et al. ANNALS OF INTERNAL MEDICINE
- Recommendations for returning genomic incidental findings? We need to talk!
- (2013) Wylie Burke et al. GENETICS IN MEDICINE
- Genetic incidental findings: autonomy regained?
- (2013) Effy Vayena et al. GENETICS IN MEDICINE
- Return of incidental findings in genomic medicine: measuring what patients value—development of an instrument to measure preferences for information from next-generation testing (IMPRINT)
- (2013) Caroline Savage Bennette et al. GENETICS IN MEDICINE
- Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing
- (2013) Barbara J. Evans GENETICS IN MEDICINE
- Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium
- (2013) Jonathan S. Berg et al. GENETICS IN MEDICINE
- Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heard
- (2013) Anne Townsend et al. GENETICS IN MEDICINE
- ACMG recommendations on incidental findings are flawed scientifically and ethically
- (2013) Neil A. Holtzman GENETICS IN MEDICINE
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
- (2013) Robert C. Green et al. GENETICS IN MEDICINE
- Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings?
- (2013) David S. Rosenblatt MOLECULAR GENETICS AND METABOLISM
- Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing
- (2013) Megan Allyse et al. TRENDS IN BIOTECHNOLOGY
- Policy challenges of clinical genome sequencing
- (2013) C. F. Wright et al. BMJ-British Medical Journal
- Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome
- (2012) Miriam Kuppermann et al. CANCER
- Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer
- (2012) Shelby D. Reed et al. GENETICS IN MEDICINE
- The Cost-Effectiveness of Primary Stroke Centers for Acute Stroke Care
- (2012) Gregory F. Guzauskas et al. STROKE
- Influence of Patient Preferences on the Cost-Effectiveness of Screening for Lynch Syndrome
- (2012) Grace Wang et al. Journal of Oncology Practice
- Future Directions in Malignant Hyperthermia Research and Patient Care
- (2011) Sharon J. Hirshey Dirksen et al. ANESTHESIA AND ANALGESIA
- Economic evaluation of targeted cancer interventions: Critical review and recommendations
- (2011) Elena B. Elkin et al. GENETICS IN MEDICINE
- A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy
- (2011) Jodie Ingles et al. HEART
- Resource Use in the Last 6 Months of Life Among Medicare Beneficiaries With Heart Failure, 2000-2007
- (2010) Kathleen T. Unroe et al. ARCHIVES OF INTERNAL MEDICINE
- Health Benefits and Cost-Effectiveness of Primary Genetic Screening for Lynch Syndrome in the General Population
- (2010) T. A. Dinh et al. Cancer Prevention Research
- Cost-Effectiveness of Genetic Testing in Family Members of Patients With Long-QT Syndrome
- (2010) Marco V. Perez et al.
- DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
- (2010) S. Wordsworth et al. EUROPEAN HEART JOURNAL
- The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
- (2010) Mercy Mvundura et al. GENETICS IN MEDICINE
- Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia
- (2009) L. Nherera et al. CURRENT MEDICAL RESEARCH AND OPINION
- Evaluating the utility of personal genomic information
- (2009) Morris W Foster et al. GENETICS IN MEDICINE
- Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular Cardiomyopathy
- (2009) Gregory M. Marcus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report—Part II
- (2009) Louis P. Garrison et al. VALUE IN HEALTH
- Variation of Breast Cancer Risk Among BRCA1/2 Carriers
- (2008) Colin B. Begg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations
- (2008) Susan M. Wolf et al. JOURNAL OF LAW MEDICINE & ETHICS
- Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes
- (2008) Margaret L. Holland et al. VALUE IN HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started